Differential antiviral effect of PEG-interferon-α-2b on HIV and HCV in the treatment of HIV/HCV co-infected patients
Gespeichert in:
| Veröffentlicht in: | AIDS (London) 2007-09, Vol.21 (14), p.1855-1865 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1865 |
|---|---|
| container_issue | 14 |
| container_start_page | 1855 |
| container_title | AIDS (London) |
| container_volume | 21 |
| creator | NEUMANN, A. U POLIS, M. A KOTTILIL, Shyam ROZENBERG, L JACKSON, J. O REITANO, K. N MCLAUGHLIN, M KORATICH, C DEWAR, R. L MASUR, H HAAGMANS, B. L |
| description | |
| doi_str_mv | 10.1097/QAD.0b013e32825eaba7 |
| format | Article |
| fullrecord | <record><control><sourceid>pascalfrancis_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1097_QAD_0b013e32825eaba7</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>19135560</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2427-5fcc433b01f55147aa36067580a2dcad527b9dd6ebaeab2d7b48fe52342d796c3</originalsourceid><addsrcrecordid>eNpdkN1KAzEQhYMoWKtv4EVuvEybn81m97K0tS0UVNDeLrPZBCPtbklWwcfyRXwmZ6kgeDXDnPkOnEPIreATwUszfZotJrzmQjklC6kd1GDOyEhkRjGtjTgnIy7zkpXK8EtyldIb51zzohiR90Xw3kXX9gH2FHB8hIibw6vtaefp43LFQtu7iG9dy76_mKxp19L1Zof_DV3PdzS0tH91tI8O-gN6DRzq00GzHeKDmWvoEfqAcromFx72yd38zjF5uV8-z9ds-7DazGdbZmUmDdPe2kwpTOa1xjQAKue50QUH2VhotDR12TS5qwEzy8bUWeGdlirDvcytGpPs5Gtjl1J0vjrGcID4WQleDdVVWF31vzrE7k7YEZKFvY_Q2pD-2FIorXOufgC0W3Dr</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Differential antiviral effect of PEG-interferon-α-2b on HIV and HCV in the treatment of HIV/HCV co-infected patients</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Journals@Ovid Complete</source><creator>NEUMANN, A. U ; POLIS, M. A ; KOTTILIL, Shyam ; ROZENBERG, L ; JACKSON, J. O ; REITANO, K. N ; MCLAUGHLIN, M ; KORATICH, C ; DEWAR, R. L ; MASUR, H ; HAAGMANS, B. L</creator><creatorcontrib>NEUMANN, A. U ; POLIS, M. A ; KOTTILIL, Shyam ; ROZENBERG, L ; JACKSON, J. O ; REITANO, K. N ; MCLAUGHLIN, M ; KORATICH, C ; DEWAR, R. L ; MASUR, H ; HAAGMANS, B. L</creatorcontrib><identifier>ISSN: 0269-9370</identifier><identifier>EISSN: 1473-5571</identifier><identifier>DOI: 10.1097/QAD.0b013e32825eaba7</identifier><language>eng</language><publisher>Hagerstown, MD: Lippincott Williams & Wilkins</publisher><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents ; Antiviral agents ; Biological and medical sciences ; Human viral diseases ; Immunodeficiencies ; Immunodeficiencies. Immunoglobulinopathies ; Immunopathology ; Infectious diseases ; Medical sciences ; Pharmacology. Drug treatments ; Viral diseases ; Viral diseases of the lymphoid tissue and the blood. Aids</subject><ispartof>AIDS (London), 2007-09, Vol.21 (14), p.1855-1865</ispartof><rights>2007 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2427-5fcc433b01f55147aa36067580a2dcad527b9dd6ebaeab2d7b48fe52342d796c3</citedby><cites>FETCH-LOGICAL-c2427-5fcc433b01f55147aa36067580a2dcad527b9dd6ebaeab2d7b48fe52342d796c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=19135560$$DView record in Pascal Francis$$Hfree_for_read</backlink></links><search><creatorcontrib>NEUMANN, A. U</creatorcontrib><creatorcontrib>POLIS, M. A</creatorcontrib><creatorcontrib>KOTTILIL, Shyam</creatorcontrib><creatorcontrib>ROZENBERG, L</creatorcontrib><creatorcontrib>JACKSON, J. O</creatorcontrib><creatorcontrib>REITANO, K. N</creatorcontrib><creatorcontrib>MCLAUGHLIN, M</creatorcontrib><creatorcontrib>KORATICH, C</creatorcontrib><creatorcontrib>DEWAR, R. L</creatorcontrib><creatorcontrib>MASUR, H</creatorcontrib><creatorcontrib>HAAGMANS, B. L</creatorcontrib><title>Differential antiviral effect of PEG-interferon-α-2b on HIV and HCV in the treatment of HIV/HCV co-infected patients</title><title>AIDS (London)</title><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Antiviral agents</subject><subject>Biological and medical sciences</subject><subject>Human viral diseases</subject><subject>Immunodeficiencies</subject><subject>Immunodeficiencies. Immunoglobulinopathies</subject><subject>Immunopathology</subject><subject>Infectious diseases</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><subject>Viral diseases</subject><subject>Viral diseases of the lymphoid tissue and the blood. Aids</subject><issn>0269-9370</issn><issn>1473-5571</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><recordid>eNpdkN1KAzEQhYMoWKtv4EVuvEybn81m97K0tS0UVNDeLrPZBCPtbklWwcfyRXwmZ6kgeDXDnPkOnEPIreATwUszfZotJrzmQjklC6kd1GDOyEhkRjGtjTgnIy7zkpXK8EtyldIb51zzohiR90Xw3kXX9gH2FHB8hIibw6vtaefp43LFQtu7iG9dy76_mKxp19L1Zof_DV3PdzS0tH91tI8O-gN6DRzq00GzHeKDmWvoEfqAcromFx72yd38zjF5uV8-z9ds-7DazGdbZmUmDdPe2kwpTOa1xjQAKue50QUH2VhotDR12TS5qwEzy8bUWeGdlirDvcytGpPs5Gtjl1J0vjrGcID4WQleDdVVWF31vzrE7k7YEZKFvY_Q2pD-2FIorXOufgC0W3Dr</recordid><startdate>200709</startdate><enddate>200709</enddate><creator>NEUMANN, A. U</creator><creator>POLIS, M. A</creator><creator>KOTTILIL, Shyam</creator><creator>ROZENBERG, L</creator><creator>JACKSON, J. O</creator><creator>REITANO, K. N</creator><creator>MCLAUGHLIN, M</creator><creator>KORATICH, C</creator><creator>DEWAR, R. L</creator><creator>MASUR, H</creator><creator>HAAGMANS, B. L</creator><general>Lippincott Williams & Wilkins</general><scope>IQODW</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>200709</creationdate><title>Differential antiviral effect of PEG-interferon-α-2b on HIV and HCV in the treatment of HIV/HCV co-infected patients</title><author>NEUMANN, A. U ; POLIS, M. A ; KOTTILIL, Shyam ; ROZENBERG, L ; JACKSON, J. O ; REITANO, K. N ; MCLAUGHLIN, M ; KORATICH, C ; DEWAR, R. L ; MASUR, H ; HAAGMANS, B. L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2427-5fcc433b01f55147aa36067580a2dcad527b9dd6ebaeab2d7b48fe52342d796c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Antiviral agents</topic><topic>Biological and medical sciences</topic><topic>Human viral diseases</topic><topic>Immunodeficiencies</topic><topic>Immunodeficiencies. Immunoglobulinopathies</topic><topic>Immunopathology</topic><topic>Infectious diseases</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><topic>Viral diseases</topic><topic>Viral diseases of the lymphoid tissue and the blood. Aids</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>NEUMANN, A. U</creatorcontrib><creatorcontrib>POLIS, M. A</creatorcontrib><creatorcontrib>KOTTILIL, Shyam</creatorcontrib><creatorcontrib>ROZENBERG, L</creatorcontrib><creatorcontrib>JACKSON, J. O</creatorcontrib><creatorcontrib>REITANO, K. N</creatorcontrib><creatorcontrib>MCLAUGHLIN, M</creatorcontrib><creatorcontrib>KORATICH, C</creatorcontrib><creatorcontrib>DEWAR, R. L</creatorcontrib><creatorcontrib>MASUR, H</creatorcontrib><creatorcontrib>HAAGMANS, B. L</creatorcontrib><collection>Pascal-Francis</collection><collection>CrossRef</collection><jtitle>AIDS (London)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>NEUMANN, A. U</au><au>POLIS, M. A</au><au>KOTTILIL, Shyam</au><au>ROZENBERG, L</au><au>JACKSON, J. O</au><au>REITANO, K. N</au><au>MCLAUGHLIN, M</au><au>KORATICH, C</au><au>DEWAR, R. L</au><au>MASUR, H</au><au>HAAGMANS, B. L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Differential antiviral effect of PEG-interferon-α-2b on HIV and HCV in the treatment of HIV/HCV co-infected patients</atitle><jtitle>AIDS (London)</jtitle><date>2007-09</date><risdate>2007</risdate><volume>21</volume><issue>14</issue><spage>1855</spage><epage>1865</epage><pages>1855-1865</pages><issn>0269-9370</issn><eissn>1473-5571</eissn><cop>Hagerstown, MD</cop><pub>Lippincott Williams & Wilkins</pub><doi>10.1097/QAD.0b013e32825eaba7</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0269-9370 |
| ispartof | AIDS (London), 2007-09, Vol.21 (14), p.1855-1865 |
| issn | 0269-9370 1473-5571 |
| language | eng |
| recordid | cdi_crossref_primary_10_1097_QAD_0b013e32825eaba7 |
| source | Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Journals@Ovid Complete |
| subjects | Antibiotics. Antiinfectious agents. Antiparasitic agents Antiviral agents Biological and medical sciences Human viral diseases Immunodeficiencies Immunodeficiencies. Immunoglobulinopathies Immunopathology Infectious diseases Medical sciences Pharmacology. Drug treatments Viral diseases Viral diseases of the lymphoid tissue and the blood. Aids |
| title | Differential antiviral effect of PEG-interferon-α-2b on HIV and HCV in the treatment of HIV/HCV co-infected patients |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T05%3A48%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pascalfrancis_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Differential%20antiviral%20effect%20of%20PEG-interferon-%CE%B1-2b%20on%20HIV%20and%20HCV%20in%20the%20treatment%20of%20HIV/HCV%20co-infected%20patients&rft.jtitle=AIDS%20(London)&rft.au=NEUMANN,%20A.%20U&rft.date=2007-09&rft.volume=21&rft.issue=14&rft.spage=1855&rft.epage=1865&rft.pages=1855-1865&rft.issn=0269-9370&rft.eissn=1473-5571&rft_id=info:doi/10.1097/QAD.0b013e32825eaba7&rft_dat=%3Cpascalfrancis_cross%3E19135560%3C/pascalfrancis_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |